3 Biotech Stocks to Buy in March

“Our life is March weather, savage and serene in one hour.” — Ralph Waldo Emerson

Substitute “biotechs” for “our life” and you have the investing version of Emerson’s quote. Depending on how binary events go, they can certainly become savage or serene quite quickly.We asked our team of experts for their top biotech picks to watch this month. Read below to […]

3 Easy Ways to Fail When Investing in Biotech Stocks

The biotech sector has the potential for outsized returns, but also extra risk not seen with larger pharmaceutical companies (and larger companies in general).Sometimes the easiest way to make money is to follow Warren Buffett’s advice and not lose it in the first place. We asked some of The Motley Fool’s biotech experts to weigh in on common mistakes investors […]

Is Xoma Corporation A Buy?

Source: Flickr user Ali T.Clinical stage biotech stocks can have nausea-inspiring pops-and-drops tied to news, and that makes them suitable for only the most risk-tolerant of investors. However, investors willing to accept the risk of loss can reap substantial rewards if promising pipeline drugs like Xoma Corp ‘s gevokizumab succeed in clinical trials. Since Xoma could begin reporting late stage […]

What You Should Know Before Watching Vice’s Special About Curing Cancer

Stephen Grupp, of the Children’s Hospital of Philadelphia, Emily Whitehead, and Vice CEO Shane Smith.Tomorrow night at 10 pm on the east and west coasts of the United States, Vice, the TV arm of the fast-growing Vice media empire, will air a special on HBO that posits that scientists are closing in on a cure for cancer.“Today in real time […]

Receptos CEO: Building for the long term – CNBC.com

Who can beat the ‘superbug’?
A new antibiotic-resistant “superbug” may have contributed to the deaths of 2 patients at Ronald Reagan-UCLA Medical Center. What companies may be on track to combat the deadly virus, with CNBC’s Meg Tirrell.
A year ago, Receptos was a billion-dollar company looking to compete with drugmakers sometimes a hundred times its size, in therapeutic areas already served […]

Cramer: The biotech that doubled in value last year

This week Jim Cramer has been highlighting the hottest biotech stocks for 2015 as a part of his series “Biotech, the Next Generation.”One of the best performing biotechs for 2014 was the orphan drug company PTC Therapeutics, which rallied 205 percent last year. Shire PLC recently acquired NPS Pharmaceuticals at a 51 percent premium to where it was trading before.This […]

Biotech stocks to watch ahead of liver disease conference

The number of patients with this chronic liver disease, which can lead to permanent liver scarring, eclipses that of hepatitis C in the U.S., RBC’s Yee said. While a significant number aren’t diagnosed, “we believe, based on survey work, that there are hundreds of thousands of patients with diagnosed NASH,” and that the global market for NASH drugs may reach […]

Tekmira Pharmaceuticals (TKMR) Surges Nearly 40%, Call Options …

MomentumOptionsTrading.com Midday Update for 8/8/2014Tekmira Pharmaceuticals (TKMR) Surges Nearly 40%, Call Options Active2:05 p.m. (EST)It has been an incredibly busy week with late nights and early morning wake-ups, but the action has been worth it.I have done extensive research over the past few weeks that has kept me well prepared in predicting this week’s continued volatility and weakness and, while […]

The New Weapon Against Disease-Spreading Insects Is Big Data …

Computer models that pinpoint the likely locations of mosquitoes and tsetse flies are helping officials target vector control efforts.Ploughing the fertile soils of the Niayes region near Dakar in Senegal is still done using beasts of burden—and Big Data is protecting these bovine beasts from an enfeebling malady that’s spread by tsetse flies.An international research team combined high-resolution maps with advances in species distribution models to […]

Using 'Big Data' approach to map relationships between human and …

Researchers at the University of Liverpool’s Institute of Infection and Global Health are building the world’s most comprehensive database describing human and animal pathogens, which can be used to prevent and tackle disease outbreaks around the globe.

The Enhanced Infectious Diseases (EID2) database has been developed by the Liverpool University Climate and Infectious Diseases of Animals (LUCINDA) team and is funded […]